クリングルファーマ㈱
Osaka, JP · 2 known investors
Find your way into クリングルファーマ㈱
Kringle Pharma develops and manufactures HGF protein-based pharmaceuticals for treating conditions including spinal cord injury, ALS, and vocal cord scarring. The company is a spin-out of Osaka University and Keio University focused on drug development in the biotech sector.
Founders & leadership
TN
Toshikazu Nakamura
安
安達喜一
Investors · 2
Frequently asked questions
- What does クリングルファーマ㈱ do?
- Kringle Pharma develops and manufactures HGF protein-based pharmaceuticals for treating conditions including spinal cord injury, ALS, and vocal cord scarring. The company is a spin-out of Osaka University and Keio University focused on drug development in the biotech sector.
- Who founded クリングルファーマ㈱?
- クリングルファーマ㈱ was founded by Toshikazu Nakamura.
- Who are クリングルファーマ㈱'s investors?
- クリングルファーマ㈱'s investors include DBJ Capital, OSAKA University Venture Capital.
- Where is クリングルファーマ㈱ headquartered?
- クリングルファーマ㈱ is headquartered in Osaka, JP.